MAP
RETA
Moody Aldrich Partners’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-51,533
| Closed | -$5.25M | – | 221 |
|
|
2023
Q2 | $5.25M | Buy |
51,533
+2,004
| +4% | +$204K | 1.02% | 31 |
|
|
2023
Q1 | $4.5M | Buy |
+49,529
| New | +$4.5M | 0.91% | 46 |
|
|
2020
Q3 | – | Sell |
-8,481
| Closed | -$1.32M | – | 186 |
|
|
2020
Q2 | $1.32M | Buy |
8,481
+1,130
| +15% | +$176K | 0.28% | 93 |
|
|
2020
Q1 | $1.06M | Sell |
7,351
-8,121
| -52% | -$1.17M | 0.32% | 91 |
|
|
2019
Q4 | $3.16M | Buy |
+15,472
| New | +$3.16M | 0.65% | 64 |
|